Adage Capital Partners Gp, L.L.C. Becton Dickinson & CO Transaction History

Adage Capital Partners Gp, L.L.C.

$51 Billion
Q1 2024

A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Becton Dickinson & CO stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 90,581 shares of BDX stock, worth $21.2 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

90,581

Previous 281,815 67.86%

Holding current value

$21.2 Million

Previous $68.7 Million 67.38%

% of portfolio

0.04%

Previous 0.15%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$233.45 - $247.73 $44.6 Million - $47.4 Million	-191,234 Reduced 67.86%	90,581 $22.4 Million
Q4 2023 Feb 14, 2024	BUY	$232.24 - $267.23 $5.43 Million - $6.25 Million	23,400 Added 9.06%	281,815 $68.7 Million
Q3 2023 Nov 14, 2023	BUY	$254.9 - $283.59 $12.8 Million - $14.3 Million	50,400 Added 24.23%	258,415 $66.8 Million
Q2 2023 Aug 14, 2023	SELL	$238.39 - $265.32 $12.3 Million - $13.7 Million	-51,653 Reduced 19.89%	208,015 $54.9 Million
Q1 2023 May 15, 2023	SELL	$229.71 - $259.35 $6.99 Million - $7.9 Million	-30,447 Reduced 10.49%	259,668 $64.3 Million

Q4 2022 Feb 14, 2023	SELL	$218.29 - $256.91 $87,316 - $102,764	-400 Reduced 0.14%	290,115 $73.8 Million
Q3 2022 Nov 14, 2022	BUY	$51.03 - $264.23 $3.25 Million - $16.8 Million	63,600 Added 28.03%	290,515 $64.7 Million
Q2 2022 Aug 15, 2022	SELL	$234.74 - $275.42 $2.46 Million - $2.89 Million	-10,500 Reduced 4.42%	226,915 $55.9 Million
Q1 2022 May 16, 2022	BUY	$243.64 - $270.48 $17.4 Million - $19.3 Million	71,400 Added 43.01%	237,415 $63.2 Million
Q4 2021 Feb 14, 2022	SELL	$230.08 - $250.94 $17.1 Million - $18.7 Million	-74,400 Reduced 30.95%	166,015 $41.7 Million
Q3 2021 Nov 15, 2021	SELL	$232.72 - $256.47 $17.3 Million - $19.1 Million	-74,400 Reduced 23.63%	240,415 $59.1 Million
Q2 2021 Aug 16, 2021	BUY	$232.65 - $254.58 $6.37 Million - $6.98 Million	27,400 Added 9.53%	314,815 $76.6 Million
Q1 2021 May 17, 2021	SELL	$232.09 - $256.88 $11.7 Million - $13 Million	-50,600 Reduced 14.97%	287,415 $69.9 Million
Q4 2020 Feb 16, 2021	SELL	$221.92 - $245.94 $20.2 Million - $22.4 Million	-91,000 Reduced 21.21%	338,015 $84.6 Million
Q3 2020 Nov 16, 2020	BUY	$215.77 - $276.76 $18.9 Million - $24.2 Million	87,610 Added 25.66%	429,015 $99.8 Million
Q2 2020 Aug 14, 2020	BUY	$219.9 - $263.41 $56.7 Million - $68 Million	258,042 Added 309.54%	341,405 $81.7 Million
Q1 2020 May 15, 2020	SELL	$195.69 - $279.01 $35.2 Million - $50.2 Million	-179,928 Reduced 68.34%	83,363 $19.2 Million
Q4 2019 Feb 14, 2020	SELL	$236.45 - $266.82 $3.51 Million - $3.96 Million	-14,852 Reduced 5.34%	263,291 $71.6 Million
Q3 2019 Nov 14, 2019	SELL	$230.58 - $256.08 $11.3 Million - $12.6 Million	-49,059 Reduced 14.99%	278,143 $70.4 Million
Q2 2019 Aug 14, 2019	BUY	$217.4 - $246.08 $13.9 Million - $15.7 Million	63,721 Added 24.18%	327,202 $82.5 Million
Q1 2019 May 15, 2019	SELL	$206.05 - $248.17 $541,087 - $651,694	-2,626 Reduced 0.99%	263,481 $65.8 Million
Q4 2018 Feb 14, 2019	SELL	$204.73 - $257.93 $12.7 Million - $15.9 Million	-61,836 Reduced 18.86%	266,107 $60 Million
Q3 2018 Nov 14, 2018	BUY	$233.07 - $256.0 $5.25 Million - $5.77 Million	22,542 Added 7.38%	327,943 $85.6 Million
Q2 2018 Aug 14, 2018	BUY	$208.1 - $233.85 $10.1 Million - $11.4 Million	48,646 Added 18.95%	305,401 $73.2 Million
Q1 2018 May 15, 2018	SELL	$205.46 - $240.27 $35.5 Million - $41.5 Million	-172,556 Reduced 40.19%	256,755 $55.6 Million
Q4 2017 Feb 14, 2018	BUY	$189.0 - $222.64 $81.1 Million - $95.6 Million	429,311	429,311 $91.9 Million

Others Institutions Holding BDX

# of Institutions

1,728

Shares Held

240M

Call Options Held

640K

Put Options Held

766K

View Full List

About BECTON DICKINSON & CO

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $66.7B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

More about BDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.

Account

Adage Capital Partners Gp, L.L.C. Becton Dickinson & CO Transaction History